Pedram Ebrahimnejad

1.8k total citations
82 papers, 1.3k citations indexed

About

Pedram Ebrahimnejad is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Pedram Ebrahimnejad has authored 82 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmaceutical Science, 26 papers in Biomaterials and 18 papers in Molecular Biology. Recurrent topics in Pedram Ebrahimnejad's work include Nanoparticle-Based Drug Delivery (20 papers), Advanced Drug Delivery Systems (19 papers) and Advancements in Transdermal Drug Delivery (14 papers). Pedram Ebrahimnejad is often cited by papers focused on Nanoparticle-Based Drug Delivery (20 papers), Advanced Drug Delivery Systems (19 papers) and Advancements in Transdermal Drug Delivery (14 papers). Pedram Ebrahimnejad collaborates with scholars based in Iran, United Kingdom and United States. Pedram Ebrahimnejad's co-authors include Ali Nokhodchi, Rassoul Dinarvand, Arezoo Sodagar Taleghani, Kofi Asare‐Addo, Fatemeh Atyabi, Azim Akbarzadeh, Fereshteh Talebpour Amiri, Mansour Jahangiri, Mahmoud Jafari and Amir Heydarinasab and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Colloid and Interface Science.

In The Last Decade

Pedram Ebrahimnejad

78 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedram Ebrahimnejad Iran 22 517 364 364 318 187 82 1.3k
D. Nagasamy Venkatesh India 10 494 1.0× 302 0.8× 367 1.0× 347 1.1× 189 1.0× 49 1.4k
Hongliang Du China 19 628 1.2× 403 1.1× 270 0.7× 506 1.6× 154 0.8× 31 1.4k
Fateme Haghiralsadat Iran 20 494 1.0× 592 1.6× 298 0.8× 411 1.3× 156 0.8× 34 1.3k
S. Maya India 19 642 1.2× 285 0.8× 298 0.8× 335 1.1× 182 1.0× 26 1.2k
Suneel Pandey India 6 422 0.8× 303 0.8× 307 0.8× 305 1.0× 166 0.9× 10 1.1k
Kalpana Nagpal India 19 493 1.0× 417 1.1× 668 1.8× 272 0.9× 146 0.8× 56 1.7k
Nemany A. N. Hanafy Egypt 21 530 1.0× 345 0.9× 208 0.6× 285 0.9× 141 0.8× 54 1.3k
Pragya Pandey India 7 420 0.8× 312 0.9× 263 0.7× 311 1.0× 160 0.9× 24 1.3k
Riyaz Ali M. Osmani India 24 533 1.0× 387 1.1× 653 1.8× 419 1.3× 167 0.9× 117 1.8k
Zhi Qu Australia 17 392 0.8× 367 1.0× 240 0.7× 216 0.7× 262 1.4× 28 1.2k

Countries citing papers authored by Pedram Ebrahimnejad

Since Specialization
Citations

This map shows the geographic impact of Pedram Ebrahimnejad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedram Ebrahimnejad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedram Ebrahimnejad more than expected).

Fields of papers citing papers by Pedram Ebrahimnejad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedram Ebrahimnejad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedram Ebrahimnejad. The network helps show where Pedram Ebrahimnejad may publish in the future.

Co-authorship network of co-authors of Pedram Ebrahimnejad

This figure shows the co-authorship network connecting the top 25 collaborators of Pedram Ebrahimnejad. A scholar is included among the top collaborators of Pedram Ebrahimnejad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedram Ebrahimnejad. Pedram Ebrahimnejad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abasi, Mozhgan, et al.. (2025). Curcumin loaded hyaluronan modified niosomes: Preparation, characterization and anti-cancer activity on triple-negative breast cancer cells. Journal of Drug Delivery Science and Technology. 108. 106869–106869.
2.
Ebrahimnejad, Pedram, et al.. (2025). Unlocking Curcumin's potential: Nano-encapsulation in mPEG-chitosan/hyaluronic acid complexes for enhanced therapeutic impact in colon cancer. Journal of Drug Delivery Science and Technology. 108. 106894–106894.
3.
Amiri, Fereshteh Talebpour, Yousef Fatahi, Pedram Ebrahimnejad, et al.. (2025). Effective topical delivery of astaxanthin via optimized chitosan-coated nanostructured lipid carriers: A promising strategy for enhanced wound healing and tissue regeneration. Journal of Drug Delivery Science and Technology. 110. 107052–107052. 1 indexed citations
4.
Negarandeh, Reza, Majid Saeedi, Katayoun Morteza‐Semnani, et al.. (2024). Synthesis and characterization of mesoporous silicate as core and low generation polyamidoamine dendrimer as shell for delivery of 5-fluorouracil from their nano complex. Journal of Drug Delivery Science and Technology. 101. 106154–106154. 1 indexed citations
5.
Seyedabadi, Mohammad, et al.. (2024). Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells. AAPS PharmSciTech. 25(7). 213–213. 11 indexed citations
6.
Moosazadeh, Mahmood, et al.. (2024). Association Between Smoking and Lipid Profile in Men Aged 35 to 70 Years: Dose–Response Analysis. American Journal of Men s Health. 18(3). 1044159351–1044159351. 3 indexed citations
7.
Babaei, Amirhossein, Maryam Moazeni, Hasan Fazli, et al.. (2024). Biofabrication of silver nanoparticles with Feijoa sellowiana tailored by box-behnken design: An eco-friendly approach to enhance antifungal properties in Children's toothpaste. Journal of Drug Delivery Science and Technology. 92. 105361–105361. 5 indexed citations
8.
Kamali, Mahsa, et al.. (2024). Exploring the Experiences of Health Care Providers and Managers in the COVID-19 Pandemic: A Summative Content Analysis. Journal of Nursing and Midwifery Sciences. 11(2).
9.
Golpour, Monireh, Pedram Ebrahimnejad, Ahmad Najafi, et al.. (2024). Green tea-mediated synthesis of silver nanoparticles: Enhanced anti-cancer activity and reduced cytotoxicity melanoma and normal murine cell lines. Inorganic Chemistry Communications. 161. 111989–111989. 15 indexed citations
10.
Ebrahimnejad, Pedram, Mohammad Seyedabadi, Amirhossein Babaei, et al.. (2024). Synergistic effect of curcumin and Piperine loaded Niosomal nanoparticles on acute pulmonary toxicity induced by Paraquat in mice. Toxicology Research. 13(6). tfae181–tfae181. 1 indexed citations
11.
Hashempour, Yalda, Shahla Rezaei, Masoud Salehipour, et al.. (2024). Co-immobilization of laccase and zinc oxide nanoparticles onto bacterial cellulose to achieve synergistic effect of photo and enzymatic catalysis for biodegradation of favipiravir. International Journal of Biological Macromolecules. 292. 139288–139288. 11 indexed citations
12.
Ebrahimnejad, Pedram, Hamid Akbari Javar, Thomas A. Weppelmann, et al.. (2023). Development of dual-functional core-shell electrospun mats with controlled release of anti-inflammatory and anti-bacterial agents for the treatment of corneal alkali burn injuries. Biomaterials Advances. 154. 213648–213648. 14 indexed citations
13.
Ebrahimnejad, Pedram, et al.. (2023). Recent advances in PLGA-based nanofibers as anticancer drug delivery systems. Journal of Drug Delivery Science and Technology. 85. 104587–104587. 23 indexed citations
14.
Ebrahimnejad, Pedram, et al.. (2021). A promising targeting system to enrich irinotecan antitumor efficacy: Folic acid targeted nanoparticles. Journal of Drug Delivery Science and Technology. 63. 102543–102543. 24 indexed citations
15.
Ebrahimnejad, Pedram, et al.. (2017). Green Synthesis of Silver Nanoparticles Using Mentha aquatic L Extract as the Reducing Agent. SHILAP Revista de lepidopterología. 24(1). 28–37. 4 indexed citations
16.
Dinarvand, Rassoul, et al.. (2016). Encapsulation of irinotecan in polymeric nanoparticles: Characterization, release kinetic and cytotoxicity evaluation. SHILAP Revista de lepidopterología. 14 indexed citations
17.
Ebrahimnejad, Pedram, et al.. (2016). Post-market Surveillance Study of Osveral, a Branded Generic Formulation of Deferasirox, and the original brand, Exjade. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 26(142). 238–244. 1 indexed citations
18.
Enayatifard, Reza, et al.. (2015). Evaluation of the effect of physical variables on in vitro release of diclofenac pellets using Box-Behnken design.. SHILAP Revista de lepidopterología. 18(7). 710–4. 2 indexed citations
19.
Akhtari, Javad, Pedram Ebrahimnejad, & Alireza Rafiei. (2015). A Review on the Use of Nanoparticles in the Release of Growth Factors. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 24(122). 424–439. 2 indexed citations
20.
Ebrahimnejad, Pedram, et al.. (2012). CYTOTOXITY EVALUATION OF DOCETAXEL NANOPARTICLES BY CULTURING HEPG2 CARCINOMA CELL LINES. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 22(90). 2–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026